Theregister
3 weeks agoArtificial intelligence
ServiceNow says GenAI has its benefits
ServiceNow assures investors that while returns from GenAI are not immediate, significant long-term benefits may reshape industries.
Generative AI's potential in pharma includes reducing product development timelines, leading to substantial cost savings. [ more ]